These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25772490)

  • 1. Identification of Covalent Bromodomain Binders through DNA Display of Small Molecules.
    Daguer JP; Zambaldo C; Abegg D; Barluenga S; Tallant C; Müller S; Adibekian A; Winssinger N
    Angew Chem Int Ed Engl; 2015 May; 54(20):6057-61. PubMed ID: 25772490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodomains and their pharmacological inhibitors.
    Gallenkamp D; Gelato KA; Haendler B; Weinmann H
    ChemMedChem; 2014 Mar; 9(3):438-64. PubMed ID: 24497428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule inhibitors of bromodomain-acetyl-lysine interactions.
    Brand M; Measures AR; Wilson BG; Cortopassi WA; Alexander R; Höss M; Hewings DS; Rooney TP; Paton RS; Conway SJ
    ACS Chem Biol; 2015 Jan; 10(1):22-39. PubMed ID: 25549280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule modulators for epigenetics targets.
    Knapp S; Weinmann H
    ChemMedChem; 2013 Nov; 8(11):1885-91. PubMed ID: 24127276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands.
    Jennings LE; Measures AR; Wilson BG; Conway SJ
    Future Med Chem; 2014 Feb; 6(2):179-204. PubMed ID: 24467243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent docking of large libraries for the discovery of chemical probes.
    London N; Miller RM; Krishnan S; Uchida K; Irwin JJ; Eidam O; Gibold L; Cimermančič P; Bonnet R; Shoichet BK; Taunton J
    Nat Chem Biol; 2014 Dec; 10(12):1066-72. PubMed ID: 25344815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.
    Zhao H; Gartenmann L; Dong J; Spiliotopoulos D; Caflisch A
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2493-6. PubMed ID: 24767840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition.
    Ghosh S; Taylor A; Chin M; Huang HR; Conery AR; Mertz JA; Salmeron A; Dakle PJ; Mele D; Cote A; Jayaram H; Setser JW; Poy F; Hatzivassiliou G; DeAlmeida-Nagata D; Sandy P; Hatton C; Romero FA; Chiang E; Reimer T; Crawford T; Pardo E; Watson VG; Tsui V; Cochran AG; Zawadzke L; Harmange JC; Audia JE; Bryant BM; Cummings RT; Magnuson SR; Grogan JL; Bellon SF; Albrecht BK; Sims RJ; Lora JM
    J Biol Chem; 2016 Jun; 291(25):13014-27. PubMed ID: 27056325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecules and their role in effective preclinical target validation.
    Clegg MA; Tomkinson NC; Prinjha RK; Humphreys PG
    Future Med Chem; 2017 Sep; 9(14):1579-1582. PubMed ID: 28828889
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical progress and pharmacology of small molecule bromodomain inhibitors.
    Theodoulou NH; Tomkinson NC; Prinjha RK; Humphreys PG
    Curr Opin Chem Biol; 2016 Aug; 33():58-66. PubMed ID: 27295577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities.
    Chekler EL; Pellegrino JA; Lanz TA; Denny RA; Flick AC; Coe J; Langille J; Basak A; Liu S; Stock IA; Sahasrabudhe P; Bonin PD; Lee K; Pletcher MT; Jones LH
    Chem Biol; 2015 Dec; 22(12):1588-96. PubMed ID: 26670081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromodomain biology and drug discovery.
    Zaware N; Zhou MM
    Nat Struct Mol Biol; 2019 Oct; 26(10):870-879. PubMed ID: 31582847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology.
    Galdeano C; Ciulli A
    Future Med Chem; 2016 Sep; 8(13):1655-80. PubMed ID: 27193077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application of small molecule bioactive probes in the identification of cellular targets].
    Zhang J; Zhou HC
    Yao Xue Xue Bao; 2012 Mar; 47(3):299-306. PubMed ID: 22645752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress of selective small molecule bromodomain-containing protein 9 inhibitors.
    Hui M; Jian Z; Peiyuan Z; Zhenwei W; Huibin Z
    Future Med Chem; 2018 Apr; 10(8):895-906. PubMed ID: 29620420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting bromodomains: epigenetic readers of lysine acetylation.
    Filippakopoulos P; Knapp S
    Nat Rev Drug Discov; 2014 May; 13(5):337-56. PubMed ID: 24751816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit.
    Gerstenberger BS; Trzupek JD; Tallant C; Fedorov O; Filippakopoulos P; Brennan PE; Fedele V; Martin S; Picaud S; Rogers C; Parikh M; Taylor A; Samas B; O'Mahony A; Berg E; Pallares G; Torrey AD; Treiber DK; Samardjiev IJ; Nasipak BT; Padilla-Benavides T; Wu Q; Imbalzano AN; Nickerson JA; Bunnage ME; Müller S; Knapp S; Owen DR
    J Med Chem; 2016 May; 59(10):4800-11. PubMed ID: 27115555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic drugs that do not target enzyme activity.
    Owen DR; Trzupek JD
    Drug Discov Today Technol; 2014 Jun; 12():e29-34. PubMed ID: 25027371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule chemical probes of microRNA function.
    Velagapudi SP; Vummidi BR; Disney MD
    Curr Opin Chem Biol; 2015 Feb; 24():97-103. PubMed ID: 25500006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.
    Hassan AH; Awad S; Al-Natour Z; Othman S; Mustafa F; Rizvi TA
    Biochem J; 2007 Feb; 402(1):125-33. PubMed ID: 17049045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.